NVS - Novartis AG

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5196.37B
Enterprise value 3228.58B
Trailing P/E 16.32
Forward P/E 113.63
PEG ratio (5-yr expected) 12.12
Price/sales (ttm)3.93
Price/book (mrq)3.86
Enterprise value/revenue 34.58
Enterprise value/EBITDA 613.51

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3-2.64%
S&P500 52-week change 310.64%
52-week high 399.84
52-week low 369.18
50-day moving average 386.06
200-day moving average 388.80

Share statistics

Avg vol (3-month) 32.57M
Avg vol (10-day) 31.87M
Shares outstanding 52.29B
Float 2.14B
% held by insiders 10.00%
% held by institutions 111.06%
Shares short (14 May 2020) 42.82M
Short ratio (14 May 2020) 41.2
Short % of float (14 May 2020) 4N/A
Short % of shares outstanding (14 May 2020) 40.10%
Shares short (prior month 14 Apr 2020) 43.07M

Dividends & splits

Forward annual dividend rate 43.09
Forward annual dividend yield 43.63%
Trailing annual dividend rate 33.04
Trailing annual dividend yield 33.57%
5-year average dividend yield 43.35
Payout ratio 495.58%
Dividend date 311 Mar 2020
Ex-dividend date 402 Mar 2020
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020


Profit margin 24.32%
Operating margin (ttm)24.80%

Management effectiveness

Return on assets (ttm)5.93%
Return on equity (ttm)15.16%

Income statement

Revenue (ttm)49.93B
Revenue per share (ttm)21.90
Quarterly revenue growth (yoy)10.90%
Gross profit (ttm)34.68B
Net income avi to common (ttm)7.45B
Diluted EPS (ttm)5.26
Quarterly earnings growth (yoy)23.20%

Balance sheet

Total cash (mrq)4.76B
Total cash per share (mrq)2.08
Total debt (mrq)36.69B
Total debt/equity (mrq)71.98
Current ratio (mrq)0.74
Book value per share (mrq)22.24

Cash flow statement

Operating cash flow (ttm)14.24B
Levered free cash flow (ttm)10.66B